BioCryst Pharmaceuticals, Inc. ( BCRX) - Key Metrics
BCRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.93 | $1.17 | $1.31 | $1.30 |
| 2025Q3 | $0.76 | $0.06 | $0.20 | $0.19 |
| 2025Q2 | $0.78 | $0.02 | $0.20 | $0.20 |
| 2025Q1 | $0.70 | $0 | -$0.13 | -$0.13 |
BCRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 1.67 |
| 2025Q3 | ? | 30.92 |
| 2025Q2 | ? | 92.30 |
| 2025Q1 | ? | 12239.18 |
BCRX
Price: $9.34
52 week price:
Earnings Per Share: -1.77 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Ebitda: -12.8 millionMarket Capitalization: 2.1 billion